Heterogeneous Condensation on Simplified Viral Envelope Protein Structures by Kawkab Ahasan (18784843)

“…The rapid initial condensation fills up the gap between the pillars, reducing the active surface area and leading to a gradual decrease and a plateau in the condensation rate. …”

Heterogeneous Condensation on Simplified Viral Envelope Protein Structures by Kawkab Ahasan (18784843)

“…The rapid initial condensation fills up the gap between the pillars, reducing the active surface area and leading to a gradual decrease and a plateau in the condensation rate. …”

Heterogeneous Condensation on Simplified Viral Envelope Protein Structures by Kawkab Ahasan (18784843)

“…The rapid initial condensation fills up the gap between the pillars, reducing the active surface area and leading to a gradual decrease and a plateau in the condensation rate. …”

Average days to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)

“…</p><p>Results</p><p>Average healing time for all wounds decreased significantly from 62.5 days in 2022 to 38.6 days in 2023, a 38.2% improvement (p < 0.001). …”

<b>Nest mass in forest tits </b><b><i>Paridae</i></b><b> </b><b>increases with elevation and decreasing body mass, promoting reproductive success</b> by Clara Wild (19246606)

“…We found that nest mass increased by ~ 60% along the elevational gradient, but the effect of canopy openness on nest mass was not significant, while nest mass decreased along the ranked species from the smallest <i>Periparus ater</i> to the medium-sized <i>Cyanistes caeruleus</i> and the largest <i>Parus major</i>. …”

Craniocaudal impulses of fore- and hindlimbs at three bar heights during take-off. by Leena Inkilä (20614460)

Chart illustrates the treated groups (BM-MSC1, BM-MSC2, AD-MSC1, AD-MSC2) increasing in cell viability over replicates, while the untreated groups (Un-BM1, Un-BM2, Un-AD1, Un-AD2)... by Alani Mohanad Khalid Ahmed (22693496)

Causal relationships between allergic diseases and significant declines in lung function: a multivariable Mendelian randomization study by Jiannan Lin (6954983)

“…However, in multivariable MR analysis, the independent effects of atopic dermatitis and allergic conjunctivitis on lung function were no longer significant. Only allergic asthma continued to show a significant causal relationship with decreased lung function (OR [95%CI]: 1.019 [1.008–1.030], <i>p</i> < .001).…”

lncCyt b cooperates with hnRNPA2B1 to modulate glycolysis and exhibits physiological significance. by Jia Li (160557)

Fig 4 - by Leena Inkilä (20614460)

Prediction of the effect of the 9 nsSNPs on AKT2 proteins’ structure and function by eight computational tools. by Sadia Afrin Runa (22504971)

Subjects:

Distribution of SNPs and their frequencies based on mutation classes. by Sadia Afrin Runa (22504971)

Subjects:

Hydrogen bond interactions between Capivasertib (red) and the AKT2 protein (blue) as predicted by molecular docking analyses. by Sadia Afrin Runa (22504971)

Subjects:

Hydrogen bond interactions between Ipatasertib (red) and the AKT2 protein (blue) as predicted by molecular docking analyses. by Sadia Afrin Runa (22504971)

Subjects:

Hydrogen bond interactions between Akt1/Akt2-IN-1 (red) and the AKT2 protein (blue) as predicted by molecular docking analyses. by Sadia Afrin Runa (22504971)

Subjects:

Predicted pathogenicity of R274H, Y265N, and R467W substitutions and their molecular mechanisms. by Sadia Afrin Runa (22504971)

Subjects:

The Fig illustrates the effects of mutations on the stability, flexibility, compactness, and interactions of the AKT2-Akt1/Akt2-IN-1 through molecular dynamics simulations. by Sadia Afrin Runa (22504971)

Subjects:

Non-covalent interactions between Capivasertib (ball stick) and the AKT2 protein as predicted by molecular docking analyses. by Sadia Afrin Runa (22504971)

Subjects:

Non-covalent interactions between Akt1/Akt2-IN-1 (ball stick) and the AKT2 protein as predicted by molecular docking analyses. by Sadia Afrin Runa (22504971)

Subjects:

Binding affinity of Akt1/Akt2-IN-1, Capivasertib, and Ipatasertib with AKT2 (wild and mutants) protein. by Sadia Afrin Runa (22504971)

Subjects: